2016-01-07

Camurus's initial public offering a success

On Thursday December 3, 2015, Camurus started its first day of trading on Nasdaq Stockholm. The share price increased considerably during the first day and Camurus is now the largest company in the biotechnology sector on Nasdaq Stockholm

The price of the Camurus share was set at SEK 57, but at closing time the share was noted at SEK 65,5, an increase of no less than 15,7 percent. The upturn meant that the market capitalization of Camurus was close to SEK 2,5 million at the end of the day. Today (January 2016) the market capitalization is about SEK 2,8 million.

Sandberg Development will remain the largest shareholder in Camurus and will hold appr. 54 percent of the total number of shares in the company.

Latest news

2019-04-10

Aimpoint granted new large FCS contract from the U.S. Military

Aimpoint has been awarded a large contract of USD 24 million from the U.S. Military for the FCS13-RE system for SAAB…

Read more

2019-04-10

Camurus’ rights issue oversubscribed

Camurus’ rights issue of 403 MSEK has been oversubscribed. The rights issue was carried out to secure financing of t…

Read more

2019-04-10

Positive results for Buvidal® in treatment for fentanyl dependence

New positive results from a Phase 3 study show that Camurus’ Buvidal® provides better treatment effect for fentanyl…

Read more

2019-04-10

Court proceedings initiated for immediate market approval of Brixadi™ in the US

Camurus’ partner, Braeburn Inc., has initiated court proceedings foran approval of Brixadi (Buvidal® in the US) and…

Read more

2019-02-26

Spin-off of GAIM from Aimpoint

Based on Aimpoint's red dot sight for fire arms, the company has developed a commercial VR platform, GAIM, which is…

Read more